DCM Shriram (DCMSHRIRAM) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
3 Feb, 2026Executive summary
Q1 FY25 saw consolidated net revenue rise 3% year-over-year to ₹2,876 crore, with PBDIT up 49% and PAT up 77% compared to Q1 FY24, led by Chemicals and Vinyl growth, while Sugar faced margin pressure from higher costs and export restrictions.
Major capex in Chemicals is nearing completion, with new caustic and power capacities commissioned and further projects in trial runs.
Profit after tax rose to ₹100.30 crore from ₹56.58 crore year-over-year.
EBITDA for the quarter was ₹273.73 crore, compared to ₹183.38 crore in Q1 FY24.
Strategic focus on capacity expansion, cost efficiency, sustainability, and new product development across business lines.
Financial highlights
Net revenues (net of excise) for Q1 FY25 were INR 2,876 crore, up from INR 2,780 crore year-over-year.
PBDIT rose 49% year-over-year to INR 274 crore.
PAT: ₹100 crore (up 77% YoY); PBIT margin improved to 6.5% from 4% YoY.
Net debt as of June 30, 2024, stood at INR 1,459 crore, up from INR 926 crore a year ago.
ROCE for the period at 14.3%, up from 13.6% for FY24.
Outlook and guidance
Expectation of gradual improvement in chemicals business as industry pressures bottom out and new projects (ECH, H2O2) add stability.
Anticipate significant capacity utilization in new caustic facilities by year-end, with optimal levels next year.
Hydrogen peroxide and epichlorohydrin plants to be commissioned in Q2 and Q3 FY25, with major revenue impact from next year.
Sugar business outlook remains stable but margin improvement depends on policy support and feedstock availability for ethanol.
Fenesta and Shriram Farm Solutions to maintain growth momentum; normal monsoon expected to support agri demand.
Latest events from DCM Shriram
- Q3 FY26 revenue up 13% YoY to ₹4,003.27 crore; ₹55 crore provision; interim dividend declared.DCMSHRIRAM
Q3 25/2623 Jan 2026 - Q2 FY25 revenue up 9% YoY, PAT up 95%, major capex and interim dividend announced.DCMSHRIRAM
Q2 24/2516 Jan 2026 - Q3 FY25 revenue up 11%, PAT up 9%, with strong Chemicals growth and major CapEx, dividend declared.DCMSHRIRAM
Q3 24/2510 Jan 2026 - Q1 FY26 saw strong growth in revenue and profits, driven by chemicals, agri, and strategic moves.DCMSHRIRAM
Q1 25/2620 Nov 2025 - FY25 saw double-digit growth, higher dividends, and major project commissioning.DCMSHRIRAM
Q4 24/2520 Nov 2025 - Strong Q2 growth led by Chemicals, Vinyl, and Fenesta, with major expansions and profit gains.DCMSHRIRAM
Q2 25/2631 Oct 2025